Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
TOKYO, May 23, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society
United States American Society Of Clinical Oncology Eisai Co Ltd Bliss Biopharmaceutical Hangzhou Co Ltd Merck Co Inc Merck Sharp Dohme
Source: finanznachrichten.de